transient impairment of glucose tolerance is possible, particularly in individuals with pre-existing insulin resistance Injection site reactions: Mild and typically localised Contraindications include active malignancy (GH-IGF-1 signalling can promote tumour growth), pituitary-dependent conditions, pregnancy, and active diabetic retinopathy
Lets delve into the remarkable advantages of IV glutathione therapy: 1
Can glutathione be combined with NAD+ IV therapy
3335, dated 1st October 2022
There is an excellent presentation from Cambridge University which outlines this: [First trimester embryonic nutrition
Iliopoulos, D., Drosatos, K., Hiyama, Y., Goldberg, I